Showing results (931-940 of 958) with videos related to
Sort By:
Pageof 96
Nature Immunology|October 21, 2022
IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammationXinhui Ni, Yi Xu, Wang Wang, et al.Hepatology (Baltimore, Md.)|January 31, 2025
Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targetsZe Zhang, Zhenpeng Zhang, Yao Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2020
Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS ManagementShiqi Li, Xinxin Wang, Zhongtao Yuan, et al.Immunity|November 15, 2023
Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesisMytrang H Do, Wei Shi, Liangliang Ji, et al.Journal of Hematology & Oncology|April 8, 2024
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trialXinxin Wang, Canrong Lu, Bo Wei, et al.Cellular & Molecular Immunology|March 8, 2019
The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infectionXiangyu Chen, Guoshuai Cao, Jialin Wu, et al.BMC Public Health|July 27, 2023
A cluster randomized trial of a comprehensive intervention nesting family and clinic into school centered implementation to reduce myopia and obesity among children and adolescents in Beijing, China: study protocolXinxin Wang, Jiajia Dang, Jieyu Liu, et al.Nature Immunology|May 27, 2014
The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cellsHaikun Wang, Jianlin Geng, Xiaomin Wen, et al.Nature Communications|October 13, 2019
Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic functionZehua Bian, Qiang Wang, Xinyu Zhou, et al.Cancer Cell|May 20, 2022
Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacyHaixia Long, Qingzhu Jia, Liuyang Wang, et al.Pageof 96